Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways - PubMed (original) (raw)
Review
doi: 10.1189/jlb.0503206. Epub 2003 Jul 22.
Affiliations
- PMID: 12960231
- DOI: 10.1189/jlb.0503206
Review
Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways
ChuHee Lee et al. J Leukoc Biol. 2003 Nov.
Abstract
Macrophages are major targets for infection by human immunodeficiency virus type 1 (HIV-1). In addition to their role as productive viral reservoirs, inappropriate activation of infected and uninfected macrophages appears to contribute to pathogenesis. HIV-1 infection requires initial interactions between the viral envelope surface glycoprotein gp120, the cell-surface protein CD4, and a chemokine receptor CCR5 or CXCR4. Besides their role in HIV-1 entry, CCR5 and CXCR4 are G protein-coupled receptors that can activate multiple intracellular signaling pathways. HIV-1 gp120 has been shown to activate signaling pathways through the chemokine receptors in several cell types including lymphocytes, neurons, and astrocytes. In some cell types, these consequences may cause cellular injury. In this review, we highlight our data demonstrating diverse signaling events that occur in primary human macrophages in response to gp120/chemokine receptor interactions. These responses include K+, Cl-, and nonselective cation currents, intracellular Ca2+ increases, and activation of several kinases including the focal adhesion-related tyrosine kinase Pyk2, mitogen-activated protein kinases (MAPK), and phosphoinositol-3 kinase. Activation of the MAPK leads to gp120-induced expression of chemokines such as monocyte chemoattractant protein-1 and macrophage-inflammatory protein-1beta and the proinflammatory cytokine tumor necrosis factor alpha. These responses establish a complex cytokine network, which may enhance or suppress HIV-1 replication. In addition, dysregulation of macrophage function by gp120/chemokine receptor signaling may contribute to local inflammation and injury and further recruit additional inflammatory and/or target cells. Targeting these cellular signaling pathways may have benefit in controlling inflammatory sequelae of HIV infection such as in neurological disease.
Similar articles
- HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling.
Del Corno M, Liu QH, Schols D, de Clercq E, Gessani S, Freedman BD, Collman RG. Del Corno M, et al. Blood. 2001 Nov 15;98(10):2909-16. doi: 10.1182/blood.v98.10.2909. Blood. 2001. PMID: 11698270 - HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation.
Liu QH, Williams DA, McManus C, Baribaud F, Doms RW, Schols D, De Clercq E, Kotlikoff MI, Collman RG, Freedman BD. Liu QH, et al. Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4832-7. doi: 10.1073/pnas.090521697. Proc Natl Acad Sci U S A. 2000. PMID: 10758170 Free PMC article. - Chemokine signaling and HIV-1 fusion mediated by macrophage CXCR4: implications for target cell tropism.
Collman RG, Yi Y, Liu QH, Freedman BD. Collman RG, et al. J Leukoc Biol. 2000 Sep;68(3):318-23. J Leukoc Biol. 2000. PMID: 10985246 - Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: Implications for neuropathogenesis.
Yi Y, Lee C, Liu QH, Freedman BD, Collman RG. Yi Y, et al. J Neurovirol. 2004;10 Suppl 1:91-6. doi: 10.1080/753312758. J Neurovirol. 2004. PMID: 14982745 Review. - HIV-1 gp120 chemokine receptor-mediated signaling in human macrophages.
Freedman BD, Liu QH, Del Corno M, Collman RG. Freedman BD, et al. Immunol Res. 2003;27(2-3):261-76. doi: 10.1385/IR:27:2-3:261. Immunol Res. 2003. PMID: 12857973 Review.
Cited by
- Cooperative interactions between neurotrophin receptors and CXCR4 regulate macrophage phenotype and susceptibility to activation by HIV.
Williams KS, Seawell JA, Zhuravleva V, Pierre K, Meeker RB. Williams KS, et al. J Neurovirol. 2024 Aug;30(4):406-422. doi: 10.1007/s13365-024-01211-0. Epub 2024 May 31. J Neurovirol. 2024. PMID: 38822196 - CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin.
Jang Y, Cho YS, Kim A, Zhou X, Kim Y, Wan Z, Moon JJ, Park H. Jang Y, et al. ACS Appl Mater Interfaces. 2024 Apr 10;16(14):17129-17144. doi: 10.1021/acsami.3c18569. Epub 2024 Mar 27. ACS Appl Mater Interfaces. 2024. PMID: 38533538 Free PMC article. - Advancing drug delivery to articular cartilage: From single to multiple strategies.
Zhao T, Li X, Li H, Deng H, Li J, Yang Z, He S, Jiang S, Sui X, Guo Q, Liu S. Zhao T, et al. Acta Pharm Sin B. 2023 Oct;13(10):4127-4148. doi: 10.1016/j.apsb.2022.11.021. Epub 2022 Nov 25. Acta Pharm Sin B. 2023. PMID: 37799383 Free PMC article. Review. - Progress in Pathological and Therapeutic Research of HIV-Related Neuropathic Pain.
Hu Y, Liu J, Zhuang R, Zhang C, Lin F, Wang J, Peng S, Zhang W. Hu Y, et al. Cell Mol Neurobiol. 2023 Oct;43(7):3343-3373. doi: 10.1007/s10571-023-01389-7. Epub 2023 Jul 20. Cell Mol Neurobiol. 2023. PMID: 37470889 Review. - Molecular Pathogenesis of Human Immunodeficiency Virus-Associated Disease of Oropharyngeal Mucosal Epithelium.
Tugizov SM. Tugizov SM. Biomedicines. 2023 May 14;11(5):1444. doi: 10.3390/biomedicines11051444. Biomedicines. 2023. PMID: 37239115 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous